<?xml version="1.0" encoding="UTF-8" ?> 

<rss version="2.0"> 
<channel> 
<title>HIV/Immunodeficiency News</title> 
<link>http://www.mdlinx.com/AllergyImmunoLinx/news.cfm/newspage/1/spec_id/21/subspec_id/350</link> 
<description>HIV/Immunodeficiency</description> 
<language>en-us</language> 
<copyright>Copyright 2009 MDLinx, Inc.</copyright>










 



<item> 
<title><![CDATA[Smoking Cessation Among Women with and at Risk for HIV: Are They Quitting]]></title> 
<link>http://www.mdlinx.com/AllergyImmunoLinx/xml-article.cfm/2960237</link> 
<pubDate>11/25/2009</pubDate> 
<description><![CDATA[<b>Journal of General Internal Medicine</b>]]></description> 
<guid>http://www.mdlinx.com/AllergyImmunoLinx/xml-article.cfm/2960237</guid>
</item> 
 

<item> 
<title><![CDATA[Effect of Calcium-Modulating Cyclophilin Ligand on Human Immunodeficiency Virus Type 1 Particle Release and Cell Surface Expression of Tetherin]]></title> 
<link>http://www.mdlinx.com/AllergyImmunoLinx/xml-article.cfm/2957332</link> 
<pubDate>11/25/2009</pubDate> 
<description><![CDATA[<b>Journal of Virology</b>]]></description> 
<guid>http://www.mdlinx.com/AllergyImmunoLinx/xml-article.cfm/2957332</guid>
</item> 
 

<item> 
<title><![CDATA[Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial]]></title> 
<link>http://www.mdlinx.com/AllergyImmunoLinx/xml-article.cfm/2961571</link> 
<pubDate>11/25/2009</pubDate> 
<description><![CDATA[<b>The Lancet - Early Online Publication</b>]]></description> 
<guid>http://www.mdlinx.com/AllergyImmunoLinx/xml-article.cfm/2961571</guid>
</item> 


 

<item> 
<title><![CDATA[Lopinavir Cerebrospinal Fluid Steady-State Trough Concentrations in HIV-Infected Adults]]></title> 
<link>http://www.mdlinx.com/AllergyImmunoLinx/xml-article.cfm/2963126</link> 
<pubDate>11/25/2009</pubDate> 
<description><![CDATA[<b>Annals of Pharmacotherapy</b>]]></description> 
<guid>http://www.mdlinx.com/AllergyImmunoLinx/xml-article.cfm/2963126</guid>
</item> 
 

<item> 
<title><![CDATA[Comparative Cell-Mediated Immunogenicity of DNA/DNA, DNA/Adenovirus Type 5 (Ad5), or Ad5/Ad5 HIV-1 Clade B gag Vaccine Prime-Boost Regimens]]></title> 
<link>http://www.mdlinx.com/AllergyImmunoLinx/xml-article.cfm/2963345</link> 
<pubDate>11/25/2009</pubDate> 
<description><![CDATA[<b>The Journal of Infectious Diseases</b>]]></description> 
<guid>http://www.mdlinx.com/AllergyImmunoLinx/xml-article.cfm/2963345</guid>
</item> 
 

<item> 
<title><![CDATA[Haematological and biochemistry laboratory abnormalities associated with splenomegaly in asymptomatic adults in Masaka, Uganda: implications for HIV biomedical prevention trials]]></title> 
<link>http://www.mdlinx.com/AllergyImmunoLinx/xml-article.cfm/2962669</link> 
<pubDate>11/25/2009</pubDate> 
<description><![CDATA[<b>Tropical Medicine &#38; International Health</b>]]></description> 
<guid>http://www.mdlinx.com/AllergyImmunoLinx/xml-article.cfm/2962669</guid>
</item> 
 
 


  


</channel> 
</rss>

